Osman Goni1, Mohammad Forhad Khan2, Md Masudur Rahman2, Md Zahid Hasan2, Faisal Bin Kader2, Nasim Sazzad2, Mahfuz Ahmed Sakib2, Barbara Romano3, Md Areeful Haque4, Raffaele Capasso5. 1. Department of Natural Sciences, Hochschule Bonn-Rhein-Sieg, 53359, Rheinbach, Germany; Department of Pharmacy, International Islamic University Chittagong, Chittagong, 4318, Bangladesh. 2. Department of Pharmacy, International Islamic University Chittagong, Chittagong, 4318, Bangladesh. 3. Department of Pharmacy, University of Naples Federico II, Naples, Italy. 4. Department of Pharmacy, International Islamic University Chittagong, Chittagong, 4318, Bangladesh; Drug & Herbal Research Centre, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, 50300, Kuala Lumpur, Malaysia. Electronic address: areeful@gmail.com. 5. Department of Agricultural Sciences, University of Naples Federico II, Portici (NA), Italy. Electronic address: rafcapas@unina.it.
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Aglaonema hookerianum Schott is an ethnomedicinally important plant used to treat a variety of diseases, including sexual and depression-like disorders. However, the scientific basis underlying the aforesaid properties have not been well justified. AIM OF THE STUDY: The present investigation aimed to investigate the anxiolytic, antidepressant and aphrodisiac potentials of methanol leaves extract of A. hookerianum (MEAH) in Swiss albino mice. MATERIALS & METHODS: Swiss albino mice (20-30 g) were orally administrated with MEAH at the doses ranging from 100 to 400 mg/kg, b.w. The elevated plus maze (EPM) and hole board test (HBT) were performed to determine the anxiolytic activity and the forced swimming test (FST) and tail suspension test (TST) were performed to determine the antidepressant activity of MEAH. Besides, the aphrodisiac activity of MEAH was conducted through the mounting behaviour and orientation behaviour analysis. Diazepam (1 mg/kg, b.w., i.p.) for EPM and HBT; fluoxetine HCl (20 mg/kg, b.w., p.o.) for FST and TST, and sildenafil (5 mg/kg, b.w., p.o.) for the mounting behaviour analysis and orientation behaviour analysis were used as reference drugs. RESULTS: The administration of the MEAH produced a strong (p<0.001) dose-dependent anxiolytic effects in both HBT and EPM tests. Likewise, the extract revealed a significant (p<0.001) reduction in the immobility time in both FST and TST as compared to the control group. Besides, the MEAH also found to possess marked aphrodisiac activity complying several facets such as an increase in the sexual performance at the highest dose (400 mg/kg, p.o.) as well as the orientation toward female mice (p<0.001) at all tested doses. CONCLUSION: Taken together, MEAH can be recommended as a potent source of neuroprotective and a libido-boosting drug candidate for the management of neurological and sexual disorders.
ETHNOPHARMACOLOGICAL RELEVANCE: Aglaonema hookerianum Schott is an ethnomedicinally important plant used to treat a variety of diseases, including sexual and depression-like disorders. However, the scientific basis underlying the aforesaid properties have not been well justified. AIM OF THE STUDY: The present investigation aimed to investigate the anxiolytic, antidepressant and aphrodisiac potentials of methanol leaves extract of A. hookerianum (MEAH) in Swiss albino mice. MATERIALS & METHODS: Swiss albino mice (20-30 g) were orally administrated with MEAH at the doses ranging from 100 to 400 mg/kg, b.w. The elevated plus maze (EPM) and hole board test (HBT) were performed to determine the anxiolytic activity and the forced swimming test (FST) and tail suspension test (TST) were performed to determine the antidepressant activity of MEAH. Besides, the aphrodisiac activity of MEAH was conducted through the mounting behaviour and orientation behaviour analysis. Diazepam (1 mg/kg, b.w., i.p.) for EPM and HBT; fluoxetine HCl (20 mg/kg, b.w., p.o.) for FST and TST, and sildenafil (5 mg/kg, b.w., p.o.) for the mounting behaviour analysis and orientation behaviour analysis were used as reference drugs. RESULTS: The administration of the MEAH produced a strong (p<0.001) dose-dependent anxiolytic effects in both HBT and EPM tests. Likewise, the extract revealed a significant (p<0.001) reduction in the immobility time in both FST and TST as compared to the control group. Besides, the MEAH also found to possess marked aphrodisiac activity complying several facets such as an increase in the sexual performance at the highest dose (400 mg/kg, p.o.) as well as the orientation toward female mice (p<0.001) at all tested doses. CONCLUSION: Taken together, MEAH can be recommended as a potent source of neuroprotective and a libido-boosting drug candidate for the management of neurological and sexual disorders.
Authors: Marius Mbiantcha; Raymond Guy Feuya Tchouya; William Nana Yousseu; Donatien Albert Atsamo; Hibrahim Foundikou; Jacques Lebibi; Franklin Gamo Zemo Journal: Inflammopharmacology Date: 2022-03-28 Impact factor: 4.473
Authors: Wang Xiaojia; Li Jianchun; Zhu Bingwen; He Xingcan; Deng Yanmei; Wang Li Journal: Evid Based Complement Alternat Med Date: 2022-02-27 Impact factor: 2.629
Authors: Antonio Wlisses da Silva; Maria Kueirislene A Ferreira; Emanuela L Rebouças; Francisco Rogenio S Mendes; Atilano Lucas Dos S Moura; Jane Eire S A de Menezes; Márcia Machado Marinho; Emmanuel Silva Marinho; Hélcio S Santos; Alexandre M R Teixeira Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2021-07-12 Impact factor: 3.000